SOPHARMA AD - Issued refusal by the Registry Agency on the transformation through merger between Sopharma AD and Unipharm AD

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 18 / 2018

Date of issue: 2018-05-02

Short name of the issuer

SOPHARMA AD

Subject

Issued refusal by the Registry Agency on the transformation through merger between Sopharma AD and Unipharm AD

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on April 30, 2018, the Registry Agency issued a refusal № 20180411164207 of the declared transformation of Unipharm AD into Sopharma AD under the Transformation Agreement of September, 14 2017 and the Additional Agreement of November, 8 2017. The companies are considering to launch a new transformation procedure as soon as possible.

Annexes

File Description

transformation refusal espi EN.pdf Issued refusal by the Registry Agency on the transformation through merger between Sopharma AD and Unipharm AD

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2018-05-02 Ognian Donev Executive director